However, the cell lineage may affect the pharmacologic sensitivity to Akt1/2 inhibition, for instance, PIK3CA-mutant breast cancer cell lines are more sensitive than PIK3CA-mutant colon cancer cell lines. The gene discussed is AKT1; the disease is breast carcinoma.